The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species

Medical Mycology

Volumn 48, Issue 2, 2010, Pages 318-327

  Badali, H ^a,b,c   Najafzadeh, M J ^a,b   Esbroeck, M Van ^d   Enden, E Van Den ^d   Tarazooie, B ^a   Meis, J F G M ^e   De Hoog, G S ^a,b  

^a CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Antifungal susceptibility testing; Black yeasts; Exophiala jeanselmei; ITS rDNA; Mycetoma

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; FUNGAL DNA; ISAVUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; RIBOSOME DNA; VORICONAZOLE;

ADULT; ANTIFUNGAL SUSCEPTIBILITY; ANTIVIRAL ACTIVITY; ARTICLE; CASE REPORT; CHEMOTHERAPY; CLINICAL EFFECTIVENESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SEQUENCE; EUMYCETOMA; EXCISION; EXOPHIALA; EXOPHIALA JEANSELMEI; EXOPHIALA OLIGOSPERMA; FOOT; FUNGAL STRAIN; FUNGUS IDENTIFICATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIVER FUNCTION TEST; LYMPHATIC DRAINAGE; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; SIDE EFFECT; TREATMENT RESPONSE;

CHAETOTHYRIALES; EXOPHIALA; EXOPHIALA JEANSELMEI; EXOPHIALA OLIGOSPERMA;

EID: 76649130531     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693780903148353     Document Type: Article

References (39)

1. McGinnis MR. Mycetoma. D ermatol Clin 1996; 14: 97-104 .
2. Hay RJ. Agents of eumycotic mycetomas. In: Ajello L, Hay RJ (eds). Topley and Wilson's Microbiology and Microbial Infections, vol.4. Mycology. London: Arnold, 2000: 487-496.
3. De Hoog GS, Guarro J, Gene J, Figueras MJ. A tlas of Clinical Fungi, 2nd ed. Utrecht/Reus: Centraalbureau voor Schimmelcul-tures/Universitat Rovira i Virgili, 2000.
4. Bittencourt AL, Londero AT. Tropical mycotic diseases. In: Doerr BW, Uehlinger E (eds). Tropical Pathology, 2nd edn. Vol.8. Berlin: Springer Verlag, 1995: 707-798.
5. Satow MM, Attili-Angelis D, De Hoog GS, et al. Selective factors involved in oil flotation isolation of black yeasts from the environment. Stud Mycol 2008; 61: 157-163 .
6. Werlinger KD, Yen Moore A. Eumycotic mycetoma caused by C ladophialophora bantiana in a patient with systemic lupus erythematous. J Am Acad Dermatology 2005; 52: 114-117 .
7. Bonifaz A, De Hoog GS, McGinnis MR, et al. Eumycetoma caused by Cladophialophora bantiana successfully treated with itraconazole. Med Mycol 2009; 47: 111-114 .
8. Guillot J, Garcia-Hermoso D, Degorce F, et al. Eumycetoma caused by Cladophialophora bantiana in a dog. J Clin Microbiol 2004; 42: 4901-4903 .
9. Badali H, Gueidan C, Najafzadeh MJ, et al. Biodiversity of the genus Cladophialophora . Stud Mycol 2008; 61: 175-191 .
10. Naka W, Harada T, Nishikawa T., Fukushiro R. A case of chromoblastomycosis with special reference to the mycology of the isolated Exophiala jeanselmei . Mykosen 1986; 29: 445-452 .
11. Nucci M, Akiti T, Barreiros G, et al. Nosocomial fungemia due to Exophiala jeanselmei var. jeanselmei and a Rhinocladiella species: newly described causes of bloodstream infection. J Clin Microbiol 2001; 39: 514-518 .
12. De Hoog GS, Takeo K, Yoshida S, e t al. Pleoanamorphic life cycle of Exophiala (Wangiella) dermatitidis . Antonie van Leeuwenhoek 1994; 65: 143-153 .
13. De Hoog GS, Vicente V, Caligiorne RB, e t al. Species diversity and polymorphism in the Exophiala spinifera clade containing opportunistic black yeast-like fungi. J Clin Microbiol 2003; 41: 4767-4778 .
14. Desnos-Ollivier M, Bretagne S, Dromer F, et al. Molecular identifi- cation of black-grain mycetoma agents. J Clin Microbiol 2006; 44: 3517-3523.
15. Gams W, Verkley GJM, Crous PW. C BS Course of Mycology, 5th ed. Utrecht: Centraalbureau voor Schimmelcultures, 2007.
16. White TJ, Bruns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: InnisMA, Gelfand DA, Sninsky JJ, White TJ (eds). PCR Protocols: A Guide to Methods and Applications. SanDiego: Academic Press, 1990; 315-322 .
17. Stamatakis A, Hoover P, Rougemont J. A rapid bootstrap algorithm for the RAxML Web-Servers. System Biol 2008; 57: 758-771 .
18. Hillis DM, Bull JJ. An empirical test of bootstrapping as a method for assessing confidence in phylogenetic analysis. System Biol 1993; 42: 182-192.
19. Clinical and Laboratory Standards Institute (CLSI) . R eference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved Standard M38-A2 ; 2nd edn : CLSI , Wayne , PA, USA , 2008 .
20. Langeron M. Mycetome a Torula jeanselmei Langeron, 1928. Nouveau type de mycetome a grains noirs. Ann Parasitol Hum Comp 1928; 6: 385-403 .
21. Murray IG, Dunkerley GE, Hughes KEA. A case of Madura foot caused by Phialophora jeanselmei . Sabouraudia 1963; 3: 175-177 .
22. Kawachi Y, Tateishi T, Shojima K, et al. Subcutaneous phaeomycotic cyst of the finger cased by E. jeanselmei : association with a wood splinter. Cutis 1995; 56: 41-43 .
23. Yamada Y, sugihara K, Van Eijk GW, e t al. Coenzyme Q system in ascomycetous black yeasts. Antonie van Leeuwenhoek 1989; 56: 349-356 .
24. Bossler AD, Richter SS, Chavez AJ, e t al. Exophiala oligosperma causing olecranon bursitis. J Clin Microbiol 2003; 41: 4779-4782.
25. Badali H, Carvalho VO, Vicente V, et al. C ladophialophora saturnica sp. nov., a new opportunistic species of Chaetothyriales revealed using molecular data. Med Mycol 2009; 47: 51-62 .
26. Nishimura K, Miyaji M. Studies on the phylogenesis of pathogenic 'black yeasts. Mycopathologia 1983; 81: 135-144 .
27. Masuda M, Naka W, Tajima S, et al. Deoxyribonucleic acid hybridization studies of Exophiala dermatitidis and Exophiala jeanselmei . Microbiol Immunol 1989; 33: 631-639 .
28. Dixon DM, Polak-Wyss A. The medically important dematiaceous fungi and their identification. Mycoses 1991; 34: 1-18 .
29. De Hoog GS. Rhinocladiella and allied genera. S tud Mycol 1977; 15: 1-144 .
30. Kawasaki M, Ishizaki H, Matsumoto T, et al. Mitochondrial DNA analysis of Exophiala jeanselmei var. lecanii-corni and Exophiala castellanii . Mycopathologia 1999; 146: 75-77 .
31. Wang L, Yokoyama K, Miyaji M, Nishimura K. Identification, classification, and phylogeny of the pathogenic Species Exophiala jeanselmei and related species by mitochondrial cytochrome b gene analysis. J Clin Microbiol 2001; 39: 4462-4467 .
32. Haase G, Sonntag L, Melzer-Krick B, de Hoog GS. Phylogenetic inference by SSU-gene analysis of members of the Herpotrichiellaceae with special reference to human pathogenic species. Stud Mycol 1999; 43: 80-97 .
33. Ameen M, Arenas R. Emerging therapeutic regimes for the management of mycetomas. Expert Opin Pharmacother 2008; 9: 2077-2085 .
34. Sabatelli F, Patel R, Mann PA, e t al. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother 2006; 50: 2009-2015 .
35. Zeng JS, Sutton DA, Fothergill AW, et al. Spectrum of clinically relevant Exophiala species in the U.S.A. J Clin Microbiol 2007; 45: 3713-3720 .
36. Fothergill AW, Rinaldi MG, Sutton DA. Antifungal susceptibility testing of Exophiala spp: a head to head comparion of amphotericin B, itraconazole, posaconazole and voriconazole. Med Mycol 2009; 47: 41-43 .
37. Guinea J, Pelaez T, Recio S. In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of Zygomycetes, Candida , Aspergillus , Fusarium , and Scedosporium species. Antimicrob Agents Chemother 2008; 52: 1396-1400 .
38. Jaffar A, Tawfiq AL, Amr SS, Madura leg due to Exophiala jeanselmei successfully treated with surgery and itraconazole therapy. Med Mycol 2009 ; 1-5 iFirst. DOI: 10.1080/13693780802669194 .
39. Loulergue P, Hot A, Dannaoui E, e t al. Successful treatment of black grain mycetoma with voriconazole. Am J Trop Med Hyge 2006; 75: 1106-1107 .